ENZ Enzo Biochem Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ENZ

Price (delayed)

$2.96

Market cap

$142.76M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$129.44M

Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.enzo.com/

Highlights

The gross profit has soared by 73% YoY and by 33% from the previous quarter
The EPS has grown by 49% from the previous quarter
Enzo Biochem's quick ratio has decreased by 27% YoY but it has increased by 10% from the previous quarter
Enzo Biochem's debt has increased by 14% YoY but it has decreased by 2.8% QoQ

Key stats

What are the main financial stats of ENZ
Market
Shares outstanding
48.23M
Market cap
$142.76M
Enterprise value
$129.44M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.29
Price to sales (P/S)
1.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.34
Earnings
Revenue
$96.55M
EBIT
-$10.63M
EBITDA
-$7.99M
Free cash flow
-$14.08M
Per share
EPS
-$0.22
Free cash flow per share
-$0.29
Book value per share
$1.29
Revenue per share
$2.01
TBVPS
$2.17
Balance sheet
Total assets
$112.03M
Total liabilities
$50.24M
Debt
$31.22M
Equity
$61.79M
Working capital
$39.93M
Liquidity
Debt to equity
0.51
Current ratio
2.33
Quick ratio
1.89
Net debt/EBITDA
1.67
Margins
EBITDA margin
-8.3%
Gross margin
41.4%
Net margin
-11%
Operating margin
-12.4%
Efficiency
Return on assets
-9.3%
Return on equity
-17.5%
Return on invested capital
-18.9%
Return on capital employed
-13%
Return on sales
-11%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENZ stock price

How has the Enzo Biochem stock price performed over time
Intraday
1.37%
1 week
1.37%
1 month
-14.45%
1 year
5.71%
YTD
17.46%
QTD
-13.95%

Financial performance

How have Enzo Biochem's revenue and profit performed over time
Revenue
$96.55M
Gross profit
$39.99M
Operating income
-$11.95M
Net income
-$10.58M
Gross margin
41.4%
Net margin
-11%
The gross profit has soared by 73% YoY and by 33% from the previous quarter
Enzo Biochem's net margin has surged by 55% QoQ
The operating margin has soared by 52% from the previous quarter
Enzo Biochem's net income has increased by 49% from the previous quarter

Growth

What is Enzo Biochem's growth rate over time

Valuation

What is Enzo Biochem stock price valuation
P/E
N/A
P/B
2.29
P/S
1.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.34
The EPS has grown by 49% from the previous quarter
The P/B is 21% less than the 5-year quarterly average of 2.9 but 15% more than the last 4 quarters average of 2.0
ENZ's equity is down by 13% YoY but it is up by 4.7% from the previous quarter
The P/S is 41% below the 5-year quarterly average of 2.5 but 5% above the last 4 quarters average of 1.4
The company's revenue rose by 20% YoY and by 14% QoQ

Efficiency

How efficient is Enzo Biochem business performance
The ROS has soared by 55% from the previous quarter
The ROIC has grown by 49% from the previous quarter
ENZ's ROA is up by 48% since the previous quarter
ENZ's ROE is up by 47% QoQ

Dividends

What is ENZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENZ.

Financial health

How did Enzo Biochem financials performed over time
ENZ's total assets is 123% greater than its total liabilities
Enzo Biochem's quick ratio has decreased by 27% YoY but it has increased by 10% from the previous quarter
The current ratio has contracted by 24% YoY but it has grown by 11% from the previous quarter
Enzo Biochem's debt is 49% lower than its equity
The debt to equity has grown by 31% YoY but it has contracted by 6% from the previous quarter
Enzo Biochem's debt has increased by 14% YoY but it has decreased by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.